Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the period ending June 30, 2019. The report serves as a notice of a capital increase approved by the Board of Directors on June 19, 2019, resulting from the exercise of stock options granted in 2009 under the company's Stock Option Plan.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure changes and historical share pricing.
| Metric | Value |
|---|---|
| Capital Increase Amount | BRL 152,073.61 |
| New Capital Stock | BRL 57,800,996,370.52 |
| New Shares Issued | 44,475 common shares (no par value) |
| Issuance Price per Share | BRL 3.41931 |
| Potential Dilution | 0.00028% |
Material Changes
The primary material change is the issuance of 44,475 new common shares, increasing the company's capital stock. This issuance was executed at a price significantly below the recent market average (BRL 3.42 issuance price vs. BRL 17.35 90-day average), consistent with the exercise of legacy stock options.
Outlook, Risks, and Commentary
The filing contains no management commentary regarding future guidance, operational outlook, risks, or contingencies. It is a procedural disclosure required by Brazilian Securities and Exchange Commission Normative Ruling No. 480/09.
Investor Verification Points
- Verify the impact of the 0.00028% dilution on existing shareholder equity.
- Confirm the total number of outstanding shares post-issuance to assess the new capital stock figure.
- Note the significant discount between the option exercise price (BRL 3.42) and the prevailing market price (approx. BRL 17.35 average over 90 days).
- Review the historical price data provided for 2016-2019 to understand share price volatility and dividend adjustments.